期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Clinical Study on Huangku Qingxin Mixture Combined with Metoprolol Tartrate Tablets for Treatment of Ventricular Premature Beat
1
作者 Juzheng FANG Yanfei XIA 《Medicinal Plant》 CAS 2019年第4期80-83,共4页
[Objectives] To observe the clinical effect and safety of Huangku Qingxin Mixture combined with Metoprolol Tartrate Tablets for patients with ventricular premature beat.[Methods] 126 patients were divided randomly int... [Objectives] To observe the clinical effect and safety of Huangku Qingxin Mixture combined with Metoprolol Tartrate Tablets for patients with ventricular premature beat.[Methods] 126 patients were divided randomly into the control group (62 cases) and the treatment group (64 cases). The control group was treated with routine western medicine, and the treatment group was treated with routine western medicine combined with Huangku Qingxin Mixture, both for one month. Then, observed the changes of Myerburg score, SAS score, symptom score and dynamic electrocardiogram in the two groups before and after treatment.[Results] The total effective rate of clinical symptoms was 82.81% in the treatment group and 64.52% in the control group. Through comparison of two groups, the difference was statistically significant ( P <0.05). The total effective rate of dynamic electrocardiogram was 84.38% in the treatment group and 58.06% in the control group. Through comparison of two groups, the difference was statistically significant ( P <0.05). Before treatment, there was no significant difference being found in the comparison of the scores of Myerburg and SAS in the two groups ( P >0.05). After treatment, Myerburg score and SAS score in the two groups were lower than those before treatment ( P <0.05);Myerburg score and SAS score in the treatment group were both better than those in the control group ( P <0.05). Before treatment, there was no significant difference in the comparison of the QT interval dispersion (QTd) and the corrected QT interval dispersion (QTcd) by Bazette formula ( P >0.05). After treatment, the results of QTd and QTcd in the two groups were lower than those before treatment ( P <0.05);the results of QTd and QTcd in the treatment group were better than those in the control group ( P <0.05).[Conclusions] The application of Huangku Qingxin Mixture combined with Metoprolol Tartrate Tablets can effectively reduce Myerburg scores and SAS scores in patients with ventricular premature beat, shorten QTd and QTcd, and i 展开更多
关键词 huangku qingxin mixture VENTRICULAR PREMATURE BEAT Myerburg SCORES SAS SCORES QT INTERVAL dispersion
下载PDF
黄苦清心合剂联合酒石酸美托洛尔片治疗室性早搏临床研究
2
作者 方居正 夏艳斐 《新中医》 CAS 2019年第4期120-123,共4页
目的:观察黄苦清心合剂联合酒石酸美托洛尔片对室性早搏患者的临床疗效及安全性。方法:126例病人随机分为对照组62例和治疗组64例,对照组采用常规西医治疗,治疗组用常规西医加黄苦清心合剂治疗,治疗1个月。观察2组治疗前后Myerburg评分... 目的:观察黄苦清心合剂联合酒石酸美托洛尔片对室性早搏患者的临床疗效及安全性。方法:126例病人随机分为对照组62例和治疗组64例,对照组采用常规西医治疗,治疗组用常规西医加黄苦清心合剂治疗,治疗1个月。观察2组治疗前后Myerburg评分、SAS评分、症候积分、动态心电图疗效的变化。结果:治疗组临床症状总有效率为82.81%,对照组为64.52%,2组比较,差异有统计学意义(P <0.05)。治疗组动态心电图总有效率为84.38%,对照组为58.06%,2组比较,差异有统计学意义(P <0.05)。治疗前,2组Myerburg、SAS评分比较,差异无统计学意义(P> 0.05)。治疗后,2组Myerburg、SAS评分均较治疗前降低(P <0.05);且治疗组Myerburg、SAS评分均优于对照组(P <0.05)。治疗前,2组QT间期离散度(QTd)及用Bazette公式校正后的QT间期离散度(QTcd)结果评分比较,差异无统计学意义(P> 0.05)。治疗后,2组QTd、QTcd结果均较治疗前降低(P <0.05);且治疗组QTd、QTcd结果均优于对照组(P <0.05)。结论:黄苦清心合剂联合酒石酸美托洛尔片可有效降低室性早搏病人Myerburg积分和SAS积分,缩短QTd及QTcd,提高病人生活质量,临床无不良反应。 展开更多
关键词 黄苦清心合剂 室性早搏 Myerburg积分 SAS评分 QT间期离散度
原文传递
黄苦清心合剂治疗室性期前收缩阴虚火旺证的临床研究
3
作者 范玄玄 王露 +3 位作者 方居正 方菲芃 刘亚勤 丰俊鹏 《南京中医药大学学报》 CAS CSCD 北大核心 2021年第2期211-215,共5页
目的观察黄苦清心合剂治疗室性期前收缩(PVB)阴虚火旺证患者的临床疗效及安全性。方法选择符合诊断标准的PVB患者92例,采用随机数字法分为2组,对照组予以酒石酸美托洛尔治疗,治疗组在对照组的基础上加服黄苦清心合剂,疗程为8周。分析患... 目的观察黄苦清心合剂治疗室性期前收缩(PVB)阴虚火旺证患者的临床疗效及安全性。方法选择符合诊断标准的PVB患者92例,采用随机数字法分为2组,对照组予以酒石酸美托洛尔治疗,治疗组在对照组的基础上加服黄苦清心合剂,疗程为8周。分析患者治疗前后中医证候积分、QT间期、校正的T波峰-末间期(Tp-ec间期)、心率变异性(HRV)及PVB次数的变化。结果治疗组中医证候总有效率高于对照组(P<0.05)。治疗后2组QT间期、Tp-ec间期、HRV及PVB次数均较治疗前改善(P<0.01),治疗组优于对照组(P<0.05~0.01)。治疗期间治疗组未出现不良反应,对照组出现1例。结论黄苦清心合剂可改善PVB阴虚火旺证患者的临床症状、降低中医证候积分和PVB次数、缩短QT间期和Tp-ec间期、改善HRV,有效治疗PVB阴虚火旺证并且安全性高。 展开更多
关键词 黄苦清心合剂 室性期前收缩 阴虚火旺证
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部